University of Helsinki
Regenerative Neuroscience: Developing Regenerative Treatments for Incurable Diseases
The number of patients with neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), Parkinson’s disease (PD), and multiple sclerosis (MS) increases with age. There is no treatment that either prevents these diseases from progressing or repairs the damage to the nerve cells.
The Regenerative Neuroscience lab is researching and developing new drug candidates for ALS, PD, and MS that prevent the disease from progressing and repair nerve cell damage. We use several different research models, such as stem cells, as well as various genetic and toxin-generated disease models. The goal of our research is to ascertain the most promising drug candidates and assess these in clinical trials for the benefit of patients.
Learn more about Tapani Koppinen and Aastha Singh from Professor Merja Voutilainen’s Regenerative Neuroscience Lab.
Graphical illustration of:
- Amyotrophic lateral sclerosis
- Parkinson’s Disease
- Multiple sclerosis
- Modelling brain cell damage in brain slice cultures and searching for new therapies
